Trial0
Sign inMap the options

Clinical trial · NCT03711890 · RECRUITING · NA

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

Request access helpRegistry record ↗

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.

Interventions

  • Optical Coherence Tomography · PROCEDURE

    Undergo OCT

  • Therapeutic Conventional Surgery · PROCEDURE

    Undergo resection will be undertaken

  • Laboratory Evaluation · DIAGNOSTIC_TEST

    Labs will be obtained to test for cancer cell derived exosomes

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN
* Immediate surgery cohort: Informed consent will be obtained
* Adult patients undergoing pancreatic resection for a presumed IPMN

Exclusion Criteria:

* Pregnant

Sites (1)

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-06-15.